Drug Scheduling Actions

Proposed Amendment; Notice of Intent: Temporary Placement of Fentanyl-Related Substances in Schedule I (December 29, 2017)

Proposed Amendment; Notice of Intent: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I (December 13, 2017)

Final Order: Placement of MT-45 Into Schedule I (December 13, 2017)

Final Rule: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in Schedule II (November 22, 2017)

Proposed Amendment; Notice of Intent: Temporary Placement of Cyclopropyl Fentanyl into Schedule I (November 21, 2017)

Temporary Amendment; Temporary Scheduling Order: Temporary Placement of FUB-AMB Into Schedule I (November 3, 2017)

Temporary Amendment; Temporary Scheduling Order: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl Into Schedule I (October 26, 2017)

Final Rule: Placement of AB-CHMINACA, AB-PINACA and THJ-2201 Into Schedule I (October 16, 2017)

Final Rule: Removal of Naldemedine From Control (September 29, 2017)

Notice of Intent: Temporary Placement of Ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl Into Schedule I (September 12, 2017)

Notice of Intent: Temporary Placement of FUB-AMB Into Schedule I (September 11, 2017)

Final Rule: Designation of Alpha-Phenylacetoacetonitrile (APAAN) as a List I Chemical (July 14, 2017)

Temporary Scheduling Order: Temporary Placement of Acryl Fentanyl Into Schedule I (July 14, 2017)

Proposed Rule: Removal of Naldemedine From Control (July 12, 2017)

Final Order: Placement of Acetyl Fentanyl Into Schedule I (June 7, 2017)

Notice of Intent: Temporary Placement of Acryl Fentanyl Into Schedule I (June 2, 2017)

Temporary Scheduling Order: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I (May 3, 2017)

Temporary Scheduling Order: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I (April 10, 2017)

Notice of Intent: Temporary Placement of 4-Fluoroisobutyryl Fentanyl Into Schedule I (March 23, 2017)

Interim Final Rule: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in Schedule II (March 23, 2017)

Final Rule: Placement of Brivaracetam Into Schedule V (March 9, 2017)

Final Rule: Placement of 10 Synthetic Cathinones Into Schedule I (March 1, 2017)

Proposed Rule: Placement of AB-CHMINACA, AB-PINACA and THJ-2201 Into Schedule I (January 27, 2017)

Temporary Order: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act (January 27, 2017)

Correction: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB-, 5F-AMB, 5F-APINACA, ADB-FUBINACA, NDMB-CHMICA and MDMB-FUBINACA) Into Schedule I (January 9, 2017)

Notice of Intent: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I (January 9, 2017)

Exempt Chemical Preparations Under the Controlled Substances Act

Order with Opportunity for Comment: Exempt Chemical Preparations Under the Controlled Substances Act (June 12, 2017)

General

Proposed Rule: Program To Hire Special Assistant United States Attorneys in Targeted Federal Judicial Districts Utilizing Diversion Control Fee Account Funds (March 21, 2017)

Import/Export

Final Rule; Delay of Effective Date: Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments (January 30, 2017)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).